Your browser doesn't support javascript.
loading
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.
Delaveris, Corleone S; Wilk, Aaron J; Riley, Nicholas M; Stark, Jessica C; Yang, Samuel S; Rogers, Angela J; Ranganath, Thanmayi; Nadeau, Kari C; Blish, Catherine A; Bertozzi, Carolyn R.
Afiliación
  • Delaveris CS; Department of Chemistry, Stanford University, Stanford CA, 94305.
  • Wilk AJ; ChEM-H, Stanford University, Stanford, CA 94305.
  • Riley NM; Stanford Medical Scientist Training Program, Stanford, CA 94305.
  • Stark JC; Stanford Immunology Program, Stanford University, Stanford, CA 94305.
  • Yang SS; Department of Medicine, Stanford University, Stanford, CA 94305.
  • Rogers AJ; Department of Chemistry, Stanford University, Stanford CA, 94305.
  • Ranganath T; Department of Chemistry, Stanford University, Stanford CA, 94305.
  • Nadeau KC; Department of Emergency Medicine, Stanford University, Stanford, CA 94305.
  • Blish CA; Department of Medicine, Stanford University, Stanford, CA 94305.
  • Bertozzi CR; Department of Medicine, Stanford University, Stanford, CA 94305.
ChemRxiv ; 2020 Dec 17.
Article en En | MEDLINE | ID: mdl-33469569
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: ChemRxiv Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: ChemRxiv Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos